Resumen
Between 2002 and 2003, 736 nonduplicate Streptococcus pneumoniae isolated from blood cultures were collected from 7 of 10 Canadian provinces (10 tertiary care centers). Microdilution broth susceptibility testing was performed using the method prescribed by the Clinical Laboratory Standards Institute. Of the isolates, 16.85% were nonsusceptible to penicillin and 5.4% were highly resistant. Of the S.pneumoniae, 14.1% had reduced susceptibility to erythromycin and 47% had been accounted for by the M phenotype. No isolates were recovered that were resistant to telithromycin. Only 6 isolates were resistant to levofloxacin and gatifloxacin. Of these, 5 strains had intermediate susceptibility to moxifloxacin and 1 was considered susceptible. The rates observed in this study are in keeping with previous surveillance studies among noninvasive isolates.
Idioma original | English |
---|---|
Páginas (desde-hasta) | 75-80 |
Número de páginas | 6 |
Publicación | Diagnostic Microbiology and Infectious Disease |
Volumen | 59 |
N.º | 1 |
DOI | |
Estado | Published - sep. 2007 |
Nota bibliográfica
Funding Information:This study was supported by an unrestricted grant from Aventis Pharmaceuticals, Canada.
ASJC Scopus Subject Areas
- Microbiology (medical)
- Infectious Diseases
PubMed: MeSH publication types
- Journal Article
- Research Support, Non-U.S. Gov't